Supporting medicines management for older people at care transitions – a theory-based analysis of a systematic review of 24 interventions by Tomlinson, Justine et al.
RESEARCH ARTICLE Open Access
Supporting medicines management for
older people at care transitions – a theory-
based analysis of a systematic review of 24
interventions
Justine Tomlinson1,2*† , Iuri Marques1† , Jonathan Silcock1 , Beth Fylan1,3 and Judith Dyson4
Abstract
Background: Older patients are at severe risk of harm from medicines following a hospital to home transition.
Interventions aiming to support successful care transitions by improving medicines management have been
implemented. This study aimed to explore which behavioural constructs have previously been targeted by
interventions, which individual behaviour change techniques have been included, and which are yet to be trialled.
Method: This study mapped the behaviour change techniques used in 24 randomised controlled trials to the
Behaviour Change Technique Taxonomy. Once elicited, techniques were further mapped to the Theoretical
Domains Framework to explore which determinants of behaviour change had been targeted, and what gaps, if any
existed.
Results: Common behaviour change techniques used were: goals and planning; feedback and monitoring; social
support; instruction on behaviour performance; and prompts/cues. These may be valuable when combined in a
complex intervention. Interventions mostly mapped to between eight and 10 domains of the Theoretical Domains
Framework. Environmental context and resources was an underrepresented domain, which should be considered
within future interventions.
Conclusion: This study has identified behaviour change techniques that could be valuable when combined within
a complex intervention aiming to support post-discharge medicines management for older people. Whilst many
interventions mapped to eight or more determinants of behaviour change, as identified within the Theoretical
Domains Framework, careful assessment of the barriers to behaviour change should be conducted prior to
intervention design to ensure all appropriate domains are targeted.
Keywords: Behaviour change, Intervention, Medicines management, Older people, Theoretical domains framework,
Systematic review
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Background
Harm from medication is estimated to cost the global
economy $42 billion USD annually [1] and causes sig-
nificant distress and burden to patients [2, 3]. Medica-
tion safety has thus been identified as an international
priority; the World Health Organization (WHO) tasks
countries to halve severe medicines-related harm by
2022 [2]. The accompanying WHO strategic framework
highlights that the systems and practices of medication
(prescribing, dispensing, administration and monitoring)
are one of four main domains to target [4].
Medication-related errors and other issues linked to
medicines management (i.e. non-adherence to regimen,
experience of side effects, etc.) can occur at multiple
stages of the patient pathway; though their likelihood is
increased during high-risk situations. It is known, for ex-
ample, that 2–3% of primary care encounters and 10% of
hospital encounters result in medication error [5]. High-
risk situations tend to be categorised by complex combi-
nations of processes, technology and human interaction
[6]. One such risky situation for medication safety oc-
curs at transitions of care [2]. A “transition of care” is a
broad term describing the transfer of a patient’s care
from one health professional and/or setting to another
[7]. Medication discrepancy, which is an unintentional
mismatch between two medication lists, is one example
of medication error that is prevalent at transitions. It is
reported that between 30 and 70% of patients experience
an unintended medication discrepancy when their care
is transferred between settings, such as during hospital
discharge [8]. Additionally, between 11 and 59% of
medication discrepancies at admission and discharge
have been reported as potentially harmful [6]. Medica-
tion safety has thus been identified as one of the core
components in successful transitions of care, alongside
educating patients to self-manage and advance care
planning [9].
Some patient groups are also at higher risk of harm
from medicines at transitions. For example, older patients
who often take multiple medicines are likely to have sev-
eral changes made to their medicines during inpatient ad-
mission. This increases the risk of harm from medicines
after hospital discharge [10] if patients are not fully aware
of changes or their primary healthcare team are not in-
formed, or do not act on changes. A study found that one
in three older people (n = 413/1116; 37%) in the UK expe-
riences medicines-related harm in the 8 weeks after dis-
charge; 3.4% (n = 14/413 cases) of which is due to
medication error and 10.9% (n = 49/413 cases) due to
non-adherence to medications [11]. There is considerable
economic impact surrounding medication errors, such as,
the healthcare resources to treat patients that have experi-
enced an error or the time taken by clinicians to resolve
any medication-related problems and legal proceedings
[6]. Ensuring appropriate medication management, the
processes and behaviours that support safe and effective
medication use, is thus a priority, especially for older
patients in the post-discharge phase.
Strategies for promoting successful transitions through
medication management have been suggested, including
improving engagement with patients, medicines recon-
ciliation and better information transfer between care
settings [12–14]. Increasing shared decision making and
encouraging meaningful conversations around medicines
has been suggested by the Department of Health and So-
cial Care in the UK [15], as one priority to overcome
medicines errors. In the UK, the National Health Service
(NHS) Long Term Plan [16] acknowledges the historical
divide between care settings and suggests new models of
care, such as integrated care systems, which aim to pro-
mote joined up care. Whilst these strategies have been
identified as possible solutions to increase medicines
safety at transitions, there is limited guidance on how to
implement them. To enact safe medicines management
at hospital discharge and in the post-discharge phase, it
is important to understand how discrete behaviours con-
tribute to positive patient outcomes [17]. It is also vital
to explore possible techniques to promote positive be-
haviour change amongst patients and healthcare profes-
sionals to increase the safety of medicines management
at transitions of care [18].
According to Michie et al. [19], complex interventions
that aim to alter behaviour have historically been poorly
designed because they are underpinned by personal ex-
perience, favoured theory or cursory analysis, rather than
scientific evidence. It is, therefore, posited that develop-
ing an understanding of the likely mechanisms of behav-
iour change is a crucial step in complex intervention
design [17]. Hence, research is needed to explore the
mechanisms of action of these effective interventions.
This is particularly important for interventions that sup-
port post-discharge medicines management for older
people. Retrospective mapping using an appropriate the-
oretical framework is one method that has proved effect-
ive previously [20]. The Behaviour Change Technique
Taxonomy (BCTT v1) [21] is an example of a framework
that can be used to characterise ‘active’ ingredients of
existing interventions. Compiled by expert consensus, to
standardise the reporting of the content of interventions,
it is an exhaustive list of 93 discrete behaviour change
techniques (BCT), grouped in 16 clusters, based on their
definitions [21]. For example, the BCTs problem solving
and action planning are grouped under ‘Goals and Plan-
ning’. Applying this taxonomy to trialled behaviour
change interventions, in order to characterise their con-
tent, and then applying the resultant techniques to a
framework, such as the Theoretical Domains Framework
(TDF), allows for comprehensive, systematic and
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coherent analysis [18]. The TDF provides a list of 14
(originally 12, Version 1) theoretical constructs relevant
to behaviour change determinants, identified from 33
psychological theories and validated by consensus [22,
23]. These are: knowledge, skills, social/professional
identity and role, beliefs about capabilities, beliefs about
consequences, motivation and goals, memory, attention
and decision processes, environmental context and re-
sources, social influences, emotion, action planning and
nature of behaviours. Each domain is associated with
component constructs that aid the researcher to con-
sider the cognitive, affective, social and environmental
influences on behaviour [24].
Through mapping intervention components to the
BCTT and TDF, we can explore which behavioural con-
structs have previously been targeted by interventions,
which individual BCTs have been included, and which
are yet to be trialled. Interventions that are tailored are
more effective than those that are not [25]; by consider-
ing existing interventions in the light of the contextual
literature relating to behavioural determinants/barriers
and facilitators to safe medicines management following
a hospital to home transition we can suggest interven-
tion components that are likeliest to be effective. The
findings from this theory-based analysis will therefore
help inform future intervention design.
Aim and objectives
This study is part of a wider programme of research in-
vestigating interventions to support successful hospital
to home transitions for older people through medication
management. A systematic review of the interventions
found in existing literature has been published previ-
ously [14]. The aim of this additional study was to con-
duct a secondary analysis of these interventions that
support either patient or healthcare professional behav-
iours to (a) investigate the possible theoretical underpin-
ning of interventions previously identified and (b)
explore potential mechanisms of behaviour change to
enhance medication management after discharge. The
specific objectives were to: identify specific behaviour
techniques for each intervention component guided by
the Behavioural Change Techniques Taxonomy v1 [21],
and pinpoint the most commonly used techniques as
well as possible gaps; and map behaviour techniques to
the Theoretical Domains Framework v1 [22] to identify
which of the possible behavioural determinants are being
targeted and which are not i.e. the likely mechanisms of
action.
Methods
A literature review of reported interventions to enhance
medicines management at hospital discharge was con-
ducted. To promote rigour and transparency, the
Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) checklist was used in the sys-
tematic review and it was registered [PROSPERO
(CRD42018086873)]. Full information, including the lit-
erature search strategy and quality appraisal, is provided
in the open-access publication [14]. Briefly, it comprised
the systematic identification in published literature of
randomised controlled trials from 2003 to 2019 from
various databases, written in English and reporting care
transition (hospital to home) interventions, that support
post-discharge medicines management, for patients aged
65 and older. A theory-based analysis was then con-
ducted by three authors, underpinned by the BCTT and
the TDF V1.
Behaviour change technique taxonomy (BCTT)
Initially, behavioural components were identified for
each intervention and mapped to the BCTT in an itera-
tive process. Firstly, three of the authors from different
professional backgrounds and experience (i.e. elderly
care pharmacist (JT), psychologist (IM) and behaviour
change expert (JD)), independently mapped each inter-
vention component to the BCTT, using published defini-
tions and examples [18, 21, 26]. BCTs were coded for
two recipients of the interventions where applicable: pa-
tients and healthcare professionals. The authors then
met to discuss individual mappings and identify and re-
solve discrepancies. After this first meeting, two of the
authors met at five different points in time to reach a
consensus on all the BCTs for each component. A final
meeting was held with all members of the team to dis-
cuss any discrepancies and agree on the final mapping.
Theoretical domains framework (TDF)
Following the mapping of each component to the BCTT,
the resultant BCTs were further mapped to eleven do-
mains of the original twelve domain TDF (v1) that were
likely to have been targeted by BCTs. The domain “na-
ture of behaviour” was excluded as this domain supports
the description and definition of the target behaviour ra-
ther than consideration of the factors that determine the
behaviour. We chose to use the original 12 domain ver-
sion of the TDF as this has the most extensive mapping
to the BCTT providing a clearer basis on which to make
decisions, and published expert consensus on the BCTs
likely to influence each TDF domain was used [18]. For
those BCTs that were not listed or had not been linked
to the TDF, a more recently published consensus exer-
cise was considered [26]. Finally, for any remaining
BCTs identified which had not or could not be classified,
the authors met to discuss and arrive a consensus, draw-
ing on their psychological and clinical knowledge and
professional expertise of healthcare practice in the NHS
in the UK (for example medicines reconciliation, when it
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is performed and how it is routinely conducted). The
final results were agreed by all of the authors.
Results
The study characteristics for each intervention have
been described elsewhere [14]. Briefly, 24 interventions
were found from 12 different countries; the majority
from Europe (n = 11) followed by the USA (n = 6),
Australia (n = 2), Canada (n = 2), Singapore (n = 2) and
Taiwan (n = 1) (see Table 1). Some interventions were
provided during hospital admission (n = 9) [27–35],
others provided in the post-discharge period (n = 6)
[36–41] and the remainder were commenced in hospital
but continued after discharge, effectively bridging the
transition (n = 9) [42–50]. Studies used varying numbers
and combinations of components within interventions
and were most often delivered by pharmacists (n = 13)
or nurses (n = 5).
Each BCT identified in this theory-based analysis (see
Table 2) was attributed to healthcare professionals, pa-
tients or both, depending on who was responsible for re-
ceiving the intervention. An example of a healthcare
professional behaviour targeted by a component was the
accuracy checking of medicines when a patient is admit-
ted to hospital. An example of a patient behaviour was
contacting a clinician after discharge if they needed ad-
vice. An example of a behaviour involving both health-
care professionals and patients was involvement and
engagement in action planning (such as in goal setting).
Behaviour change techniques linked to medicines
management at transitions
The studies that used the most discrete BCTs were
Ravn-Nielsen et al. (n = 45) [50], Ahmad et al. (n = 44)
[37] and Chan et al. (n = 39) [46], the majority of which
targeted patient behaviours. All three of these interven-
tions made use of motivational interviewing, a multifa-
ceted behaviour change technique, which accounts for
the large number of BCTs. In contrast, the interventions
that used the least number of techniques were Hockly
et al. (n = 3) [33], Tamblyn et al. (n = 3) [35], Gurwitz
et al. (n = 3) [38], Tong et al. (n = 7) [32] and Char et al.
(n = 9) [40]. These tended to focus solely on information
transfer between care providers [32, 33, 38] or medicines
reconciliation [35, 40].
The results presented below start by describing the
most and least popular BCT groupings (those with the
largest or least number of BCTs reported within the
group). Subsequently, the most and least reported indi-
vidual techniques will be described. This means that
whilst a grouping may not have been popular, certain
techniques may feature in many, if not the majority, of
interventions. A brief example is the grouping Associa-
tions, which is one of the least popular groupings as only
two out of a possible eight techniques have been re-
ported. However, one of the individual techniques
(prompts and cues) is used by 22 of the 24 interventions.
The most widely used BCT grouping was Goals and
Planning. This group contains techniques focused on
setting, reviewing and solving issues around goals.
Within this grouping, the majority of components were
aimed at patient behaviours (n = 49), followed by those
where both patient and healthcare professional behav-
iours were targeted (n = 40). The groupings Feedback
and Monitoring (ongoing monitoring and review of be-
haviours and outcomes) and Social Support (emotional,
practical or unspecified) were also well represented
within the interventions. Intervention components that
focused on feedback and monitoring targeted primarily
patient behaviours, with only two studies focusing on
both behaviours [41, 50]. Ravn-Nielsen et al.’s interven-
tion [50] offered the patient feedback on outcomes of
behaviour during a 30-min motivational interview at dis-
charge, which included education and self-management
coaching. They also communicated outcomes verbally to
the healthcare professional when problems were identi-
fied and transferred information to the primary care pro-
vider. Tuttle et al. [41] similarly provided feedback on
outcomes to the prescriber and offered support to pa-
tients by reviewing their self-management strategies.
Those interventions that focused on healthcare profes-
sional behaviours used predominantly feedback on out-
comes of behaviour, most often by transferring discharge
information between care providers to alert them to medi-
cation changes, prompting action [27, 31, 44, 46]. Three
interventions monitored outcomes without offering feed-
back to the patient [28, 45, 47]. This was most often via
medication review where monitoring of therapeutic goals
was conducted, without patient involvement. For those
studies focusing on patient behaviours, the majority used
feedback on the behaviour (n = 15), self-monitoring of the
behaviour (n = 14) and self-monitoring of outcome (n =
14).
Although a large number of interventions mentioned
techniques linked to social support, the majority (n = 16)
did not specify what support was provided. In nine inter-
ventions the social support specified was practical and in
six interventions the support was emotional [30, 37, 43,
46, 49, 50]. For those coded as practical support, six tar-
geted healthcare professional behaviours, four targeted
patient behaviours and five targeted both. Examples of
practical support for professionals included collaboration
between hospital clinicians and General Practitioners
[42], and hospital pharmacies communicating with com-
munity pharmacies to resolve prescription issues [46].
Examples of practical support for patients included self-
management educational programmes [43], adherence
support [37] and home visits that promoted self-
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Table 1 Study characteristics
Study
details
Participants and setting Intervention components
Interventions commenced during hospital admission
Basger
et al. [31]
216 elderly patients admitted to a small private hospital, taking
≥5 medicines, Australia
Medication counselling, Medicines reconciliation, Medication review




162 patients admitted for unplanned causes to the medical
admissions unit, taking ≥3 long term medicines, Northern Ireland
Preparation of full medication history, Medicines reconciliation,
Patient education and discharge counselling, Pharmaceutical




400 patients, admitted to the medical acute unit, Denmark Structured medication review, Medicines reconciliation,
Recommendations for change reported to clinician, Medication




33 patients, taking ≥4 medicines, UK Information transfer
Lalonde
et al. [29]
83 patients, being discharged with ≥2 medicines changes,
Canada
Medication Discharge Plan created and given to patient at
discharge, Transfer of information to Primary Care Provider and
Community Pharmacist by fax
Legrain
et al. [30]
665 patients, admitted to the acute geriatric unit with stays
longer than 5 days, France
Comprehensive chronic medication review, Medicines
reconciliation, Patient education and self-management discussion,




762 elderly patients, admitted to medical wards, taking ≥4 long
term medicines OR one high risk medicines OR previous
admission within last 6 months OR given an IV antibiotic on day
one of admission, Northern Ireland
Medicines reconciliation, Medication review, Counselling, Medicines
record sheet, Information transfer
Tamblyn
et al. [35]
4656 patients, discharged from internal medicine, cardiac or
thoracic surgery units, Canada
Electronic medicines reconciliation, Information transfer
Tong
et al. [32]
832 patients, admitted to general medical unit at an adult major
referral hospital, Australia
Personalised medication management plan
Interventions commenced at hospital admission and continued post-discharge
Buurman
et al. [48]
674 elderly patients, admitted to the internal medicine ward,
Netherlands
Medicines reconciliation, Discussion with Primary Care Provider and
additional support enabled, Home visit for patient education
Casas
et al. [43]
155 patients with COPD and minimum admission length of 48
h in two tertiary hospitals, Belgium and Spain
Educational programme (2 h) on self-management, Information
transfer, Post-discharge telephone calls, Web-based call centre
Chan
et al. [46]
699 patients, admitted to internal medicines, family medicines,
cardiology or neurology wards at a general safety net hospital
and trauma centre, USA
Patient education, Self-management coaching, Medicines reconcili-




750 elderly patients, with a long-term condition, with admission
to large hospital/ service delivery system, USA
Personalised patient-held record, Home visit for education, Self-




400 elderly patients (> 80 years) admitted to two internal
medicines wards at a University Hospital, Sweden
Medicines reconciliation, Medication review, Patient education,




126 elderly patients, admitted to large medical hospital with hip
fracture due to falling, Taiwan
Individualised discharge plan, Information brochure, Patient
education, Home visit, Post-discharge telephone calls, Medicines
helpline, Collaboration with Primary Care Provider
Koehler
et al. [45]
41 elderly patients, taking ≥5 long term medicines and with ≥3
chronic conditions, admitted to a University Hospital, USA
Pharmacist-led medicines reconciliation, Medication review, Patient
education including self-management, Post-discharge telephone
call, Personal health record, Information transfer
Lee et al.
[47]
840 patients, admitted to medical ward of tertiary hospital and at
high risk of readmission, Singapore
Patient education, Medicines reconciliation, Medication review,




974 patients, taking ≥5 medicines, admitted to the acute
admission wards, Denmark
Structured medication review, Information transfer, Medicines
reconciliation,
30-min motivational interview with patient at discharge for
education and self-management, Post-discharge telephone calls
Tomlinson et al. BMC Health Services Research          (2021) 21:890 Page 5 of 17
management [49]. For components coded as emotional
support, all helped patients cope with medicines man-
agement after hospital discharge. Examples included em-
powerment [43] and coaching techniques [46] for self-
management at home.
The least popular groupings, reported only by two in-
terventions each were Comparison of Behaviour (learn-
ing by performing the behaviour or seeing how
behaviour should be performed) [41, 49] and Covert
Learning (encouraging behaviour through imaging re-
ward, punishment and consequences) [37, 50]. These
targeted patient behaviours only. An example of Com-
parison of Behaviour is rehearsal or role-play of intended
behaviour [49]. An example of Covert Learning is motiv-
ational interviewing [50]. There were two groupings that
did not feature in any of the interventions identified:
Identity and Scheduled Consequences.
Although some groupings were not used frequently in
the identified interventions, individual BCTs within
these groupings were popular across the majority of
studies. Four well utilised techniques were:
a) Instruction on how to perform the behaviour
(belonging to the grouping Shaping Knowledge), for
example the component patient and carer
education [36];
b) Information about health consequences (belonging
to the grouping Natural Consequences), for example
the component motivational interview at hospital
discharge [50];
c) Prompts and cues (belonging to the grouping
Associations), for example the component individual
care plan shared across care teams [43]; and
d) Credible source (belonging to the grouping
Comparison of Outcomes), for example component
personalised medication record sheet containing
instructions for the patient [28].
The remainder of the techniques were used less fre-
quently within the studies (see Table 2).
Theoretical domains linked to post-discharge medication
management
Six interventions included components that encom-
passed all domains of the TDF [28, 36, 37, 41, 46, 50]
(see Table 3). Most of the others utilised between eight
and 10 of the domains. The three least complex inter-
ventions focused only on healthcare professional behav-
iours [33, 35, 38] and targeted the fewest domains (four
to five domains). All three of these interventions were
electronic based and served to transfer information [33,
38] or highlight medicines reconciliation issues [35].
Motivation and Goals, Action Planning and Knowledge
were the only domains that were prevalent within all
studies. Social and Professional Role and Memory, Atten-
tion and Decision Processes featured in 23 of the 24 in-
terventions. The least utilised domain was
Environmental Context and Resources, with only six in-
terventions incorporating this [28, 36, 37, 41, 46, 50].
Emotion (n = 15 studies) was the second least repre-
sented domain.
Discussion
This study has identified the common BCTs and target
theoretical domains of 24 interventions that aimed to
support post-discharge medicines management for older
Table 1 Study characteristics (Continued)
Study
details




340 elderly patients, taking ≥5 long term medicines, discharged
from general or academic hospitals, Netherlands
Medication review, Medication counselling using cognitive
behaviour techniques, Home visit, Medicines reconciliation,




200 patients, taking ≥5 long term medicines, attending first
outpatient clinic appointment following recent stay in hospital,
Singapore
Medicines reconciliation, Collaboration with Primary Care Provider,
Best possible medication history created for patient
Gurwitz
et al. [38]
3661 elderly patients, discharged from hospital for any admission,
USA




25 elderly patients, discharged from tertiary care academic
medical centre for any type of admission, USA




872 elderly patients, from 10 hospitals following an emergency
admission and taking ≥2 medicines, UK
Home visit, Medication review, Patient education, Collaboration




159 patients, discharged from large tertiary-referral hospital fol-
lowing acute illness and detection of chronic kidney disease
stage 3–5, USA
Home visit, Medicines reconciliation, Medication review, Patient
education and self-management strategies, Information transfer
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people. This has allowed an exploration of the potential
mechanisms of behaviour change of these trialled inter-
ventions to enhance medicines management after dis-
charge. Analysis of findings showed that the most
prevalent BCT groupings were Goals and Planning,
Feedback and Monitoring and Social Support. These are
valuable aspects of medication management, for ex-
ample, defined plans for adherence, monitoring and
follow-up, who should be involved when, how and why,
and what support the patient may need, should be in
place. Some groupings, although rarely used, had a num-
ber of BCTs that were prevalent across interventions. In-
dividual BCTs included: instruction on how to perform
the behaviour (Shaping Knowledge) or prompts and cues
(Associations). Although the groupings were not popular,
the individual techniques are core components of patient
education about how to manage medicines after a hos-
pital stay and are therefore important to any interven-
tion of this kind. For example, in order for patients to
successfully manage their medicines after discharge, it is
crucial that they are given specific instructions about
which medicines to take, how and when.
Common determinants of post-discharge medicines
management include: disruption in the patients’ medi-
cine knowledge base and routines caused by hospitalisa-
tion (likely to be mapped to TDF domains action
planning, knowledge), knowledge gaps and the need for
new information [51, 52] (knowledge), the need to
develop new routines [51, 53] (action planning), the
need for temporary practical support [51–53] (beliefs
about capabilities), whether or not a person considered
managing medicines their own responsibility [51] (role
and identity), and the relationship between healthcare
professionals and patient [52]. The included interven-
tions addressed many of these. For example, knowledge
gaps was considered in all but three interventions
through “instruction on how to perform the behaviour”
(exceptions: [33, 35, 38]). Disruption to and the need to
develop new routines was addressed through a range of
strategies with all but four studies using goal setting (ex-
ceptions: [33, 35, 38, 39]. Less frequently used strategies
to support routines included action planning [49], con-
tracting [30] and prompts or cues [47, 49]. The need for
support was addressed by the majority (exceptions: [29, 33,
35, 38, 40, 48]. The need to promote the patient as having
shared responsibility for their medicines was potentially
through interventions that included social support, persua-
sion about capability and mental rehearsal of successful
performance, one of which was included in all interventions
except six (exceptions: [29, 30, 33, 35, 38, 40]).
As discussed above some of the interventions included
many intervention components/BCTs. Whilst doing so
does ensure that a wide range of behavioural determi-
nants are addressed and there is strong evidence that
multifaceted interventions are effective [54], this can be
an expensive approach and lead to wasted effort and
Table 3 TDF domains coded within interventions
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resources. Tailoring to determinants/need is therefore
both effective and economical [25]. Equally, some of our
included studies had interventions including very few
components which may not have addressed key determi-
nants. The interventions with the fewest BCTs were
aimed at supporting provider clinical behaviour rather
than patient behaviour; these were restricted to
prompts/cues, action planning and feedback [33, 38] or
problem solving, reviewing and identifying discrepancies
in behaviours and goals [35]. Key barriers for healthcare
professionals include lack of time and low self-efficacy
[55], not addressed by the BCTs proposed by Hockly
et al. [33], Tamblyn et al. [35] and Gurwitz et al. [38].
A small number of interventions focused solely on
tasks aimed at healthcare professionals, suggesting lack
of patient involvement and therefore limited exploration
of patients’ individual needs. Considering the patient
goes home often with complex regimens, it is vital that
patients are involved in discussion and decisions about
their medicines [56]. Hence it is likely that the interven-
tions that only focus on healthcare professional behav-
iours would have benefitted from involving patients and
their carers at some point in the intervention. To this ef-
fect, the majority of interventions offered components
focused on both patient and healthcare professional be-
haviours, further strengthening the argument that target-
ing patient behaviours is crucial to the success of any
intervention aimed at medicines management. Putting
the patient at the centre of their care is likely to result in
better outcomes [57, 58]. Based on the findings, it is
clear that priority has been given to patient behaviours
in most of the interventions in recognition that patients
should have an active role in their care. However, what
remains unclear is how these BCTs were implemented
and consequently whether behaviours were adopted ef-
fectively, and what the extent of the patient involvement
was, since the interventions descriptions within the stud-
ies were lacking in specific detail. Our findings suggest
any future intervention should focus on harnessing indi-
vidual patient strategies and formalise them to ensure
effective management, even when the patients have
returned home.
Interventions targeting patient behaviours were pre-
dominantly prescriptive (such as providing written or
verbal information, rather than working with them in
partnership). Only a very small number of interventions
involved the patient significantly (for example through
role play, counselling and motivational interviewing)
through strategies which can highlight potential issues
before they happen and address any concerns that pa-
tients may have. However, even these interventions did
not offer sufficient detail as to what activities entailed,
such as in the case of ‘counselling’. In pharmacy practice
and research, counselling is a term frequently used to
describe a brief medicines consultation or the provision
of specific advice on medicines use. This is not extended
or person-centred counselling that might be provided by
a therapist or specialist nurse. It is unclear, however,
from the interventions described what the term ‘counsel-
ling’ meant, which not only makes it difficult to replicate
these components, but the extent to which these inter-
ventions helped the patient cannot be ascertained.
It is also unclear whether pharmacists had the relevant
skills to deliver in-depth counselling or motivational inter-
viewing interventions. Whilst the UK pharmacy curricu-
lum includes relevant learning outcomes related to the
demonstration of effective consultation skills and working
with patients to decide a course of action [59], it is not at
all clear that this means defining problems from the pa-
tient’s perspective (as true counselling would) or identify-
ing personal goals (as motivational interviewing would).
Whilst there is evidence to support the effectiveness of
motivational interviewing for medicines management [60]
and this has influenced modern undergraduate curricula;
it remains unclear if these skills are widespread or utilised
effectively without further professional development [61,
62]. Many studies mentioned healthcare professional
training but they did not describe the content and depth
of this training [30, 31, 39, 41, 44, 45, 48]. Ravn-Nielsen
et al. [50] and Ahmad et al. [37] provided a medication re-
view workshop and motivational interviewing course for
their study pharmacists. These courses were delivered
over two or days three and it is unknown whether this
was a suitable course length for becoming proficient in
motivational interviewing. Difficulties identifying and rep-
licating essential core components of interventions is an
established challenge to other practitioners who wish to
utilise them. Despite guidance calling for an improvement
in the completeness of reporting for interventions [63],
the studies within this review did not allow for detailed
descriptions of what, why, when and how for each compo-
nent to be identified.
All interventions had components spanning the TDF.
Only one domain was underrepresented: Environmental
Context and Resources. Interventions that mapped to
this domain, had components that involved seeing pa-
tients in their own homes and included the removal of
old medicines or product standardisation whilst in hos-
pital. Whilst a lesser reported barrier than those cited
above, this was identified in the literature [51–53].
Therefore, it might prove useful for any intervention that
includes home visits to remove unnecessary medicines
as that will not only reduce confusion and complexity
but will inherently help the patient reconcile it in their
own minds. Barriers to medicines reconciliation for pa-
tients and healthcare professionals were generally not re-
ported in the included papers. Similarly environmental
barriers such as time pressures or lack of human
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resource (clinical staff, formal or informal carers) have
been identified in the literature [55, 64–66] but not in-
cluded in interventions. For example, a study of primary
care practitioners (doctors, nurses and pharmacists)
identified environmental issues including time as the
second greatest barrier to safe prescribing for frail
patients [67].
Additionally, Emotion was poorly represented through-
out the studies which is perhaps surprising since medi-
cation management can be an emotional experience for
patients [56]. One possible explanation for the lack of
BCTs linked to emotion could be that the barriers to be-
haviour change were not fully considered during inter-
vention development. Without assessment of these
barriers and behavioural determinants prior to interven-
tion design, it is difficult to effectively target the mech-
anism of action for behaviour change within the local
context. Furthermore, unless a theoretical approach is
used to assess barriers, cognitive bias may lead to failure
to fully recognise or report barriers [68]. For these rea-
sons, it is imperative to use a theoretical approach to
assessing barriers and designing interventions.
One of the striking findings was that the outcomes in-
vestigated were rarely behaviour focused. Rather, the
majority of interventions focused on outcomes related to
error, harm and health in general, and did not appear to
link these desired outcomes with the behaviours that
would help these to be achieved. Whilst these clinical
outcomes are important, recording changes in behaviour
following implementation of new interventions, would
allow for the investigation of whether the intervention
was effective in helping patients cope with their medica-
tion management across the pathway, particularly at
transitions, an area still under researched to date. Simi-
larly, very few interventions stated that they were under-
pinned by a theory of behaviour change (n = 4;
McKeeham and Coulton’s discharge plan model [42];
theory of planned behaviour [37]; conceptual framework
of integrated practice units [47]; 5As model of behaviour
change [41]), an essential tenet of complex intervention
design [17]. Consequently, the majority of these inter-
ventions were task rather than behaviour driven. Many
of the interventions within this study included a medi-
cines reconciliation component, for example. Whilst lit-
erature pertaining to the barriers to effective medicines
reconciliation, from the perspective of healthcare profes-
sionals [55] and patients [69] exists, they are mainly task
orientated. Barriers such as limited resource, inaccurate
tools or unclear information [55] do not lend themselves
readily to BCTs without deeper examination of the
underpinning behavioural determinants. Although the
majority of interventions within this study did not expli-
citly aim to change behaviour, it is likely that they facili-
tated change due to the nature of some components,
such as motivational interviewing and counselling. Fu-
ture interventions should therefore also focus on the
measurement of efficiency and efficacy linked to behav-
iour change.
For purposes of the analysis, every intervention was
broken into its individual components. However, it is
important to acknowledge that although every compo-
nent was analysed individually, their effects cannot be
taken in isolation. When considered individually, it
might be a weak point but in the context of the full
intervention and in interaction with the other compo-
nents, clinical effectiveness might be greater. In other
words, the effectiveness of the intervention is greater
than the sum of the effectiveness of each component.
Finally, complex intervention design guidance illus-
trates the importance of involving patients and other key
stakeholders in the co-design of such interventions [17,
70]. Only three studies [28, 30, 45] documented having
designed the studies with key stakeholders (for example
healthcare professionals), however none explicitly men-
tioned patient or public involvement. In the UK there is
a drive to involve patients at every stage of healthcare,
including design and development of interventions. Pa-
tients are generally willing to and want to be involved in
decisions that affect their care, and having the opportun-
ity to participate in co-design can highlight important
patient behaviours, goals, priorities and concerns that
would otherwise remain undetected [70].
Strengths and limitations
A strength of this study is linked to the use of multiple
sources of information to map intervention components
to BCTT and the TDF. Specifically, analysis drew from
the established literature on the BCTs and TDF, the au-
thors’ multidisciplinary expertise and experience, and
relevant local and national healthcare policies and guide-
lines. This was particularly useful to counteract the limi-
tation linked to a lack of detail about crucial
components in each intervention. Because many of the
interventions lacked clarity about specific behaviours in
each component, the authors made a number of coding
assumptions based on their own professional research
and experience as well as policies and guidelines. For ex-
ample, where interventions described medication review,
the authors assumed a number of steps expected to en-
sure a comprehensive review of medicines. Another ex-
ample of this pertains to interventions where motivation
interviewing is described as a component. Although it
was not possible to ascertain what motivational inter-
viewing entailed, experience and expertise in the field of
Psychology and healthcare allowed for agreement
amongst the authors regarding a number of assumptions
made, when coding these components to the BCTT and
TDF. Additionally, several iterative discussions were held
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to ensure a consensus was reached for every single inter-
vention component. To further strengthen analysis,
study authors were contacted where clarification was
needed, although many did not respond. For this reason,
and despite the authors’ efforts, it is possible that inter-
pretation for each component may have overestimated
the number of steps expected compared to what really
may have happened in each intervention.
To ensure uniformity, the authors also made every at-
tempt to standardise analysis for every intervention. To
accomplish this, common components were identified
across all interventions to ensure they were analysed in
the same way. For example, for all interventions where
medicines reconciliation took place, the authors assumed
that this component involved the same BCTs and was
performed to the same quality expected, unless explicitly
stated otherwise.
Finally, in some instances, mapping intervention com-
ponents to the BCTT was not straightforward and some
components were not a perfect fit. In such instances,
this limitation was overcome by initially using different
literature sources [18, 22, 26]. Subsequently, the authors
met at different occasions to reach a consensus, again
drawing from their own experience and expertise in
research, psychology and healthcare in the UK.
Conclusions
This theory-based analysis has identified certain BCT
groupings and discrete BCTs that are common amongst
studies aiming to support successful care transitions
through medication management. We offer insights for
the development of a novel intervention that incorpo-
rates those BCTs with potential impact, but also those
that appear underutilised. Goals and Planning, Feedback
and Monitoring and Social Support, along with instruc-
tion of how to perform the behaviour and prompts/ cues
are elements that could be valuable when combined
within a complex intervention. Whilst many interven-
tions mapped to eight or more determinants of behav-
iour change, as identified within the TDF, careful
assessment of the barriers to behaviour change should
be conducted in the first instance to ensure all appropri-
ate domains are targeted. Environmental context and re-
sources was an underrepresented domain and should be
considered within future interventions.
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